Major Achievements

In a bid to create a globally competitive biopharmaceutical industry that addresses the country’s major concerns around barriers to affordable healthcare, the Union Minister of Science & Technology, launched the Innovate in India (I3) program on 30th June 2017, in New Delhi. The programme of DBT, with a funding to the tune of US$ 250 million, is a first of its kind mission that brings together industry and academia to promote entrepreneurship and indigenous manufacturing in the bio-pharmaceutical sector. This flagship program of the Government of India, in collaboration with the World Bank, will be implemented by the Biotechnology Industry Research Assistance Council (BIRAC), a Public-Sector Enterprise set up by DBT.